Can-Fite BioPharma (CANF) Tops Q1 EPS by 19c
Tweet
Share
E-mailGet Alerts CANF Hot Sheet
Join SI Premium – FREE
Can-Fite BioPharma (NYSE: CANF) reported Q1 EPS of $0.00, $0.19 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $196 thousand.
For earnings history and earnings-related data on Can-Fite BioPharma (CANF) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
